Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
about
Treatment for Barrett's oesophagusThe evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed!Proton pump inhibitors and risk of periampullary cancers--A nested case-control studyHistory, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesisAcid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysisAnimal models and therapeutic molecular targets of cancer: utility and limitations.Chemoprevention of esophageal adenocarcinomaElevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus.Acid-suppressive Medications and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus(Gut 2014;63:1229-1237).TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohortAntitumor Activity of Cytotoxic Cyclooxygenase-2 InhibitorsMechanisms of disease: Carcinogenesis in Barrett's esophagus.Single-dose safety and pharmacokinetic evaluation of fluorocoxib A: pilot study of novel cyclooxygenase-2-targeted optical imaging agent in a canine modelConsequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.Role of gastrin-peptides in Barrett's and colorectal carcinogenesis.Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma.Barrett esophagus: what a mouse model can teach us about human diseaseSystematic review: Cyclo-oxygenase-2 in human oesophageal adenocarcinogenesis.Molecular basis of Barrett's oesophagus and oesophageal adenocarcinomaGastrin - active participant or bystander in gastric carcinogenesis?Design, synthesis, and structure-activity relationship studies of fluorescent inhibitors of cycloxygenase-2 as targeted optical imaging agentsMolecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivoA retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.Gastrin, inflammation, and carcinogenesis.Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells.[I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation.Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?Melatonin in Prevention of the Sequence from Reflux Esophagitis to Barrett's Esophagus and Esophageal Adenocarcinoma: Experimental and Clinical Perspectives
P2860
Q24240701-30680C86-9146-43F4-968B-551658F667A5Q28218616-68313938-202A-4373-830E-7BC77CABC2BCQ28385784-04E0804C-92BD-4F5E-A1CA-FFB8F09D9F6EQ33786336-FFC7A8B8-2AAC-4BE5-ACEA-B3B63E5987C5Q34255451-B07CC3D5-E5CC-43A2-9D8C-B772D953ED39Q34352867-28BBB386-7DBA-4F0C-919A-0EC2D6ABD133Q34386828-F13E709B-0CAD-415B-80C5-ABC58EC65F97Q34408890-D204AB9B-9D48-494D-BEF3-377F5C3CEEB1Q35116562-1AF2A9E0-DB55-4BA7-B52F-BDD4B6F2C7D9Q35430468-7EAE0C5D-ED7E-4A7C-BAD1-372AAC58A1B2Q35760858-BA5B83BF-51EB-441C-A541-89387DE4BA46Q36121287-4BF83AE5-9CB0-46B0-8BC4-20D002FB1EECQ36304065-B3D6E46D-8CC4-4AF2-A1D6-07E7B4910052Q36356814-D07BFEC2-E5A9-4A1F-8283-155F45740537Q36376528-D31B5D55-6C08-43EA-9A5D-93D5ADB47FF8Q36450478-B8B16355-1B90-49FC-B08D-B12C5C77852CQ36510119-07DEE3DC-7A7F-402B-A980-11D0A6D671F9Q36556299-880E076A-6FCA-4B2D-9962-8E088FD35B43Q36632320-D76574B0-4801-4D78-8FCF-AD2CD4E273C5Q36662322-CB5B2E0B-EB65-4937-8F50-1DF0CFC94BE8Q36664970-A14785F5-5DFE-4371-B9F1-3A4F50A307D6Q36779116-AC527ECA-71F8-43FC-8105-C2A53D9C321BQ36900405-60400720-ADB5-42F8-9377-58DA73E573DFQ37524960-FA8B3494-8698-4E89-BFB0-1D38D9BB86CAQ37631370-CAA2818B-E4C9-4A0D-A820-C414B0904E85Q38018063-0E75789E-EF8A-4904-A2D0-CF6E83B88716Q38631128-9BC36FAF-372F-470C-952A-7B49647DD72DQ40425709-D67D1C84-9394-4893-81A3-D099844D5BDBQ42189926-3BBB57DE-8432-42FA-ADB9-DD4583916992Q53277927-756D8BF1-8E60-487B-8003-0D838A4937AAQ57114887-526C0DB4-36F4-4B39-8815-98CF0BAA4B09
P2860
Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
@en
type
label
Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
@en
prefLabel
Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
@en
P2093
P1476
Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
@en
P2093
Marco R Novelli
Pierre Lao-Sirieix
Rebecca C Fitzgerald
Salem I Abdalla
P304
P356
10.1158/1078-0432.CCR-04-0015
P407
P577
2004-07-01T00:00:00Z